韩日免费在线观看视频a,日韩欧美群交P内射捆绑,最新、最快、最全的久久,狠狠色丁香九九婷婷综合

咨詢電話:13308436663

當前位置:首頁  >  技術文章  >  C1 Esterase Inhibitor (C1-INH)說明書

C1 Esterase Inhibitor (C1-INH)說明書

更新時間:2023-10-24      點擊次數:1700

C1 Esterase Inhibitor (C1-INH)說明書

11.png

產品描述
The protease inhibitor C1-INH prevents the spontaneous activation of complement and limits consumption of C2 and C4 by rapidly inactivating C1r, C1s and MASP2. It is the only plasma serine protease inhibitor (Serpin) capable of interacting with and inhibiting activated C1. C1-INH interacts with the catalytic sites of both C1r and C1s. The interaction with activated C1r and C1s is covalent resulting in complexes which are stable to SDS. The binding of C1-INH to activated C1 releases both C1r and C1s from the complex leaving C1q bound to the immune complex. The released complexes contain four molecules: C1-INH-C1r-C1s-C1-INH. The reaction of C1 esterase inhibitor with activated C1 is very fast with the estimated half-life of C1r and C1s being approximately 15 seconds in serum. In fact, at serum concentrations of C1- INH little or no additional C4 or C2 activation occurs 3 min after immune complexes are added because all the C1r and C1s molecules have been inactivated and removed from the C1q which remains bound to the immune complex (Ross, G.D. (1986); Morley, B.J. and Walport, M.J. (2000); Rother, K., et al. (1998); Ziccardi, R.J. (1982a and 1982b); Morgan, B.P. (1990)). C1-INH is thought to bind to and stabilize unactivated C1r and C1s in the C1 complex thus retarding their spontaneous activation (Ziccardi, RJ. (1982b)).
C1-INH plays an important role in suppression of inflammation and control of vascular permeability. Through its ability to inhibit complement proteases (C1r, C1s and MASP2) and to express a variety of other biological functions (Davis III, A.E. et al. (2008)) C1-INH is able to regulate inflammatory reactions in sepsis, endotoxic shock, ischemia-reperfusion injury, transplantation, and other bacterial and parasitic infections. Through its ability to control contact system activation it inhibits bradykinin generation and this controls vascular permeability. This function is most apparent in patients with a physical or functional deficiency of C1-INH. Hereditary angioedema (HAE) patients suffer from enhanced blood vessel permeability and tissue swelling or edema. Most patients are heterozygous and have 15% to 30 % of the normal level of functional C1- INH in blood.
產品性質
Sizes Available: 1000 µg/vial
Concentration: 1.0 mg/mL (see Certificate of Analysis for actual concentration)
Form: Frozen liquid
Activity: >90 % active protein
Purity: >95 % by SDS PAGE
Buffer: 10 mM sodium phosphate, 145 mM NaCl, pH 7.3
Extinction Coeff. A280 nm = 0.45 at 1.0 mg/mL
Molecular Weight: 110,000 Da (single chain)
Preservative: None, 0.22 µm filtered.
Source: Normal human serum (shown by certified tests to be negative for HBsAg, HTLV-I/II, STS, and for antibodies to HCV, HIV-1 and HIV-II).
Precautions: Use normal precautions for handling human blood products.
注意事項
This protein is purified from human serum and therefore precautions appropriate for handling any blood-derived product must be used even though the source was shown by certified tests to be negative for HBsAg, HTLV-I/II, STS, and for antibodies to HCV, HIV-1 and HIV-II.
運輸及保存方法
-70℃ or below.Avoid freeze/thaw.
產品用途
C1-INH has an apparent molecular weight of 110,000 Da. It is a single chain protein that is highly glycosylated with approximately 30 to 40% carbohydrate. It is synthesized as a 500 amino acid protein. Removal if the signal peptide results in a plasma protein that contains 478 amino acids. The calculated molecular weight based on amino acids is 53,000 g/mole, however due to extensive glycosylation its mass is closer to 75,000. It runs abnormally on many gel systems giving apparent molecular weights from 90,000 to 115,000 MW. The glycosylation sites include six N-linked and six or seven O-linked sites. C1-INH is an extremely acidic protein with a pI of less than 3.0.
The genetic disorder HAE is caused by a partial deficiency of C1-INH. Replacement therapy with a C1-INH concentrate produced by a number of drug companies has been approved for use in both Europe and the USA. These concentrates are administered intravenously and increase blood levels of C1-INH 2- to 3-fold. A typical treatment includes administration of 1000 Units (approximately 200 mg) and the blood level may remain elevated for 2-4 days.


貨號品名規(guī)格品牌
78AH10007-1000ugC1 Esterase Inhibitor (C1-INH)1000ugBIOHUB



掃碼關注

郵箱:xs1@78bio.com

地址:上海市浦東新區(qū)川沙新鎮(zhèn)6619號

版權所有©2025 上海起發(fā)生物科技有限公司 All Rights Reserved    備案號:滬ICP備2022022359號-2    sitemap.xml    管理登陸    技術支持:化工儀器網
夫妻性生活在线免费视频| 国产一区二区区在线观看| 少妇被黑人爽到高潮喷水| 91香蕉一二三区在线观看| 欧美不卡一区| 国产精品久久久久久精品三| 亚洲国产精品无码第一区| 大鸡巴肏穴视频| 男生插女孩下面免费网站| 99在线观看| 美人被强行糟蹋np 各种play| 真人日比给我看| 国产亚洲欧美传媒麻豆精品| 被公疯狂玩弄的年轻人妻| 噢美操大骚逼操的好不好| 日本一区二区三区经典视频| 国产做a爱一级毛片久久| 国产免费av片在线观看| 黑人大鸡吧操逼流水视频| 亚洲国产精品综合久久网络| 熟妇乱子伦视频在线播放| 亚洲精品专区永久免费区| 久久久久久久久性色av| 狼友网精品视频在线观看| 爆乳上司julia中文字幕| 操逼好爽好爽视频免费看| 想外国人干逼吃奶舔舔鸡| 欧美残忍鞭打视频一15| 男人日女人骚逼| 骚鸡巴配骚逼逼| 国产午夜老熟女视频福利| 公交车被cao得合不拢腿视频| 同房后出血还有黄色液体| 五月天丁香综合激情六月| 日本精品免费一区在线观看| 日韩成人在线观看你懂的| 成人短视频在线观看网址| 亚拍一区 在线视频系列| 亚洲日韩一区精品射精| 老司机在线一区二区三区| 欧美国产日韩二区一区在线|